1 completed, 1 terminated, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Colonic Cancer: new trials by email Literature Review of Colonic Cancer trials Research Report on Colonic Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer Rivaroxaban 10 MG - Deep Venous Thrombosis, Colonic Cancer | Phase 4 | Unknown | Hospital do Servidor Publico Estadual | 68 | 2022-06-01 | 2022-03-31 |
| Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases Colonic resection, Chemotherapy- scheme - Colonic Cancer, Unresectable Metastasis Originating in Colonic Cancer | Phase 4 | Terminated | Hospital Universitari de Bellvitge | 107 | 2013-12-01 | 2021-03-16 |
| Effect of Postoperative Laxative on Bowel Function After Colonic Surgery Magnesia, Placebo - Colonic Cancer | Phase 4 | Completed | Hvidovre University Hospital | 56 | 2007-01-01 | 2009-02-11 |
Colonic Neoplasms (3) · Neoplasm Metastasis (1) · Venous Thrombosis (1)
Colonic Diseases (3) · Colorectal Neoplasms (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Bevacizumab (1) · FOLFOXIRI protocol (1) · Folfox protocol (1) · IFL protocol (1) · Magnesium Oxide (1) · Panitumumab (1) · Rivaroxaban (1)
Hospital Universitari de Bellvitge (1) · Hospital do Servidor Publico Estadual (1) · Hvidovre University Hospital (1)
Brazil (1) · Denmark (1) · Spain (1)
Carlos Moreno Sanz (1) · Eduardo Targarona Soler (1) · Jens Andersen, MD (1)